Uttroside B

N/A

Report date: 2022/03/11 10:08:46
NME

Base Information

Drug NameUttroside B
Drug Alias NameUttroside-B
ClassificationSmall molecules > Heterocyclic drugsNatural product/Extract > Plants extract
Mechanisms of ActionMitogen-activated protein kinase modulatorsSerine/threonine-protein kinase mTOR modulators
TargetsMitogen-activated protein kinaseSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsLiver NeoplasmsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQ Biomed IncRajiv Gandhi Cancer Institute And Research CenterOklahoma Medical Research Foundation
China Registration ClassN/A

Develop Information

Active CompaniesQ Biomed IncRajiv Gandhi Cancer Institute And Research CenterOklahoma Medical Research Foundation
Inactive CompaniesN/A
Active IndicationsLiver NeoplasmsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A